Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Oasmia Pharmaceutical AB | 35,000 | net | 08 Jul 2021 | tx 1+35,000 |
| Nanexa AB | 20,000 | net | 13 Jul 2021 | tx 1+20,000 |
| HMED | 3,000 | net | 17 Dec 2019 | tx 1+3,000 |
| AddLife AB | 1,500 | net | 07 Feb 2022 | tx 1+1,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Feb 2022 | PURCHASE | AddLife AB | 1,500 | 199.33 SEK | |
| 13 Jul 2021 | PURCHASE | Nanexa AB | 20,000 | 5.00 SEK | |
| 08 Jul 2021 | PURCHASE | Oasmia Pharmaceutical AB | 35,000 | 2.99 SEK | first after silence |
| 17 Dec 2019 | PURCHASE | HMED | 3,000 | 71.00 SEK |
1 purchase reported after at least 12 months of silence — most recent on 08 Jul 2021.